Skip to content
Home › 13F recaps › Q3 2026 › TMO

Which funds bought or sold TMO in Q3 2026?

Thermo Fisher Scientific Inc. 16 funds bought, 16 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$5.9B. See also what famous investors say about TMO.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold TMO, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (16)

FundChangeEst. $Now
Fidelity
Asset manager
Added+57.4%+$5.5B$15.0B
JPMorgan
Bank & broker
Added+22.7%+$1.3B$7.1B
BlackRock
Index giant
Added+4%+$842M$21.7B
Lone Pine
Hedge fund
New+$673M$673M
Holocene
Hedge fund
Added+1035.7%+$361M$396M
Ameriprise
Asset manager
Added+33.4%+$349M$1.4B
Maverick
Hedge fund
New+$201M$201M
Invesco
Asset manager
Added+10.9%+$160M$1.6B
Arrowstreet
Quant & multi-strategy
Added+22.2%+$151M$831M
Amundi
Asset manager
Added+11.6%+$142M$1.4B
Susquehanna
Quant & multi-strategy
Added+210.9%+$99M$145M
Bridgewater
Hedge fund
Added+1094.4%+$96M$104M
AllianceBernstein
Asset manager
Added+5.6%+$70M$1.3B
Wells Fargo
Bank & broker
Added+6.1%+$60M$1.0B
Fisher Investments
Asset manager
Added+2.6%+$50M$2.0B
Temasek
Sovereign & pension
Added+3.7%+$29M$814M

Sold (16)

FundChangeEst. $Now
Viking
Hedge fund
Trimmed-52.5%−$687M$621M
Farallon
Hedge fund
Trimmed-57.5%−$407M$301M
D1
Growth / crossover
Trimmed-57.7%−$318M$234M
D. E. Shaw
Quant & multi-strategy
Trimmed-73.1%−$317M$116M
QRT
Quant & multi-strategy
Trimmed-94.5%−$314M$18M
Citadel
Quant & multi-strategy
Trimmed-74%−$287M$101M
UBS
Bank & broker
Trimmed-16.3%−$277M$1.4B
Balyasny
Quant & multi-strategy
Trimmed-84.2%−$256M$48M
Schwab
Index giant
Trimmed-9.1%−$192M$1.9B
Glenview
Hedge fund
Trimmed-29.2%−$124M$300M
Man Group
Quant & multi-strategy
Trimmed-63.1%−$83M$49M
PRIMECAP
Growth / crossover
Trimmed-4.4%−$59M$1.3B
Tudor
Hedge fund
Sold out−$36M—
Jennison
Growth / crossover
Trimmed-18.9%−$34M$147M
Baillie Gifford
Growth / crossover
Trimmed-6.3%−$27M$409M
Duquesne
Family office & foundation
Sold out−$10M—

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.